| Visit 1 – screening (-21 to -1 days) | Visit 2 - first vaccination (day 0) | Visit 3 - 1 day after | Visit 4 - 3 days after (+1 day) | Visit 5 - 1 week after (±2 days) | Visit 6 - 15 days after (+2 days) | Visit 7 - 1 month after (±5 days) | Visit 8 - 6 months after (±14 days) | |
---|---|---|---|---|---|---|---|---|---|
 |  | Pre-vaccination | Post-vaccination (1 hour) |  | |||||
Inform consent | × |  |  |  |  |  |  |  |  |
Medical history and demographics | × |  |  |  |  |  |  |  |  |
Physical examination | × |  | × | × | × | × | x | × | × |
Vital signsa | × | × | × | × | × | × | x | × | × |
Haematology labsb | × |  |  |  |  |  |  |  |  |
Chemistry labs (liver, renal panelc) | × |  |  |  |  |  |  |  |  |
Dengue immunoglobulin Gd | × |  |  |  |  |  |  |  |  |
Urine pregnancy teste | × | × |  |  |  |  |  |  |  |
Adverse eventsf | × | × |  | × |  |  | x |  |  |
Concomitant medications | × | × |  | × |  |  | x |  |  |
Blood sampling in relation to YF17D vaccination |  | ×g |  | × | × | × |  | × | × |
Assessment for clinical symptoms (local and general symptoms) |  |  | × | × | × | × | x |  |  |